H858 - Web - 1067 x 667 Logo.png

Save the Date for August 2023

 The RISE Part D Master Class
CMS audit readiness, claims data management, formulary design and clinical intervention for better member outcomes

The RISE Part D Master Class is the only available opportunity for health plan executives to combine learnings on essential Part D issues, such as the Final Rule, closure of the coverage gap, program audit protocol changes, as well as best practices for contracting, formulary design, and achieving member experience quality measures. Through highly researched topics, this conference is curated to provide a unique opportunity for pharmacists, PBMs, compliance, claims data, vendor oversight, audit, and all other Part D professionals to gain a wide scope of knowledge and practicable tactics to ensure plan success and the best outcomes for members.

 

 

Stay tuned for details on next year's event.

Who Should Attend

Medical directors and other executives from health plans and hospital networks that work with CMS and offer Part D benefits, executives in such areas as:

  • Compliance
  • Pharmacy operations
  • Finance
  • Vendor management
  • FDR/ delegation oversight
  • Coverage determinations, appeals, and grievances review
  • Medicare auditing
  • Information technology
  • Claims and prescription drug event management

Pharmacy Benefit Managers (PBM) :

  • Claim approvals/denials
  • Compliance
  • Claim and prescription drug event management
  • Pharmacy operations

Other Professionals :

  • CMS audit consultants
  • CMS audit validation consultants
  • Compliance auditors
  • Legal consultants
  • Data management/ software providers
  • Health law attorneys

Top Reasons to Attend

Attendees return to this event year after year. View a few of the reasons attendees joined us for our last event:

  • Recent audit experience case studies: success stories, train wrecks, and what CMS is looking at 

  • How to ensure that your internal processes don't inadvertently throw up FWA red flags 

  • An overview of what’s in the Final Rule - know what to comply with in 2023 

  • Brands and rebates versus biosimilars - which perspective should you take and other formulary design considerations 

  • Current state of MTM rules  

  • Best practices to identify and mitigate pain points that might cause member abrasion with CAHPS  

  • Master best practices in PDE management to avoid stress during the annual DIR reconciliation